FindTrial
Sign In

To test the safety of hydration mist on eyes during usage.

A study to evaluate the ophthalmologic safety of the hydrating mist in healthy female subjects after daily use (3 days).

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053058
Enrollment
33
Registered
2023-05-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Hydrating mist: Route of Administration: Topical Dosage: Quantity sufficient Dosage Regimen: Once a day Treatment Period: 3 days Control Intervention1: NA: NA

Sponsors

DPKA Universal Consumer Ventures Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Female healthy adult subjects with age 18-45 years 2.Subject is in good health condition. 3.Subjects willing to refrain from use of other similar products during the study.

Exclusion criteria

Exclusion criteria: 1.Female with age less than 18 or more than 45 years of age 2.Pregnant/lactating mothers 3.Subjects with eye infection and sensitive eyes

Design outcomes

Primary

MeasureTime frame
1.Scoring of ocular reactions of cornea, iris and conjunctivae will be recorded after application of the hydrating mist. 2.Ophthalmologist evaluation of watering of eyes is measured by local irritation score after treatment with hydrating mist. 3.Ocular discomfort scores will be graded by the subjects after treatment with hydrating mist.Timepoint: Day 1, Day 2, Day 3—

Secondary

MeasureTime frame
Not ApplicableTimepoint: Not Applicable—

Countries

India

Contacts

Public ContactMeena Dalal

TrialGuna Private Limited

chetana_tn@yahoo.com8867125414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026